Skip to main content
MEMPHASYS LIMITED. logo

MEMPHASYS LIMITED. — Investor Relations & Filings

Ticker · MEM ISIN · AU000000MEM5 LEI · 549300RZ3LBXHF3WXL97 ASX Professional, scientific and technical activities
Filings indexed 1,220 across all filing types
Latest filing 2012-06-24 Regulatory Filings
Country AU Australia
Listing ASX MEM

About MEMPHASYS LIMITED.

https://www.memphasys.com/

Memphasys Limited is a biotechnology company specializing in the development of advanced cell separation and reproductive biotechnology solutions. The company's core technology platform utilizes proprietary membranes and electrophoresis to isolate high-quality cells from biological fluids. Its flagship product, the Felix™ system, is an automated device designed for the rapid separation of high-quality sperm from semen samples for use in human assisted reproductive technology (ART) procedures. This technology aims to improve clinical outcomes by selecting sperm with lower DNA fragmentation and higher motility compared to traditional centrifuge-based techniques. Beyond human fertility, the company applies its bio-separation expertise to animal health, including diagnostic tools for stallion fertility. Memphasys focuses on providing innovative solutions that enhance efficiency and success rates in the global reproductive health market.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice 4 pages 54.0KB
Regulatory Filings
2012-06-24 English
Change in substantial holding 4 pages 969.3KB
Regulatory Filings
2012-06-24 English
NuSep General Meeting presentation 2012 26 pages 1.1MB
Regulatory Filings
2012-06-21 English
Results of Meeting 2 pages 155.7KB
Regulatory Filings
2012-06-21 English
NuSep Settles NxGen Legal Case 2 pages 38.4KB
Regulatory Filings
2012-06-13 English
NuSep Investor Presentation 15 pages 876.1KB
Regulatory Filings
2012-06-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.